Hudson Edge Investment Partners’s Merck MRK Stock Holding History

Hudson Edge Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,849	Closed	-$482K	–	158
2024 Q4	$482K	Hold	4,849	–	–	0.09%	105
2024 Q3	$551K	Hold	4,849	–	–	0.1%	95
2024 Q2	$600K	Hold	4,849	–	–	0.12%	84
2024 Q1	$640K	Sell	4,849 -11	-0.2%	-$1.36K	0.12%	79
2023 Q4	$530K	Sell	4,860 -15	-0.3%	-$1.56K	0.12%	87
2023 Q3	$502K	Buy	+4,875	New	+$525K	0.16%	84
2023 Q2	–	Sell	-4,875	Closed	-$519K	–	130
2023 Q1	$519K	Hold	4,875	–	–	0.16%	95
2022 Q4	$541K	Sell	4,875 -15	-0.3%	-$1.53K	0.18%	99
2022 Q3	$421K	Hold	4,890	–	–	0.16%	121
2022 Q2	$446K	Hold	4,890	–	–	0.16%	117
2022 Q1	$401K	Hold	4,890	–	–	0.13%	127
2021 Q4	$375K	Sell	4,890 -80	-2%	-$6.37K	0.12%	128
2021 Q3	$373K	Sell	4,970 -350	-7%	-$26.6K	0.12%	126
2021 Q2	$414K	Sell	5,320 -276	-5%	-$20.5K	0.13%	126
2021 Q1	$412K	Sell	5,596 -63	-1%	-$4.65K	0.14%	116
2020 Q4	$442K	Hold	5,659	–	–	0.16%	115
2020 Q3	$448K	Hold	5,659	–	–	0.18%	113
2020 Q2	$418K	Hold	5,659	–	–	0.13%	102
2020 Q1	$415K	Hold	5,659	–	–	0.16%	86
2019 Q4	$491K	Hold	5,659	–	–	0.13%	120
2019 Q3	$455K	Hold	5,659	–	–	0.13%	109
2019 Q2	$453K	Hold	5,659	–	–	0.13%	98
2019 Q1	$449K	Hold	5,659	–	–	0.14%	77
2018 Q4	$413K	Hold	5,659	–	–	0.13%	109
2018 Q3	$383K	Hold	5,659	–	–	0.07%	134
2018 Q2	$328K	Hold	5,659	–	–	0.06%	140
2018 Q1	$294K	Sell	5,659 -629	-10%	-$34K	0.04%	135
2017 Q4	$338K	Sell	6,288 -1,572	-20%	-$87.1K	0.05%	136
2017 Q3	$480K	Sell	7,860 -314	-4%	-$19K	0.07%	100
2017 Q2	$500K	Hold	8,174	–	–	0.07%	107
2017 Q1	$496K	Hold	8,174	–	–	0.07%	109
2016 Q4	$459K	Sell	8,174 -105	-1%	-$6.14K	0.06%	117
2016 Q3	$493K	Sell	8,279 -198,392	-96%	-$11.6M	0.07%	95
2016 Q2	$11.4M	Sell	206,671 -83,824	-29%	-$4.46M	1.7%	35
2016 Q1	$14.7M	Sell	290,495 -30,093	-9%	-$1.47M	1.45%	27
2015 Q4	$16.2M	Sell	320,588 -359,988	-53%	-$18.1M	1.56%	26
2015 Q3	$32.1M	Buy	680,576 +672,506	+8,333%	+$35.7M	1.73%	33
2015 Q2	$438K	Hold	8,070	–	–	0.02%	123
2015 Q1	$443K	Sell	8,070 -630	-7%	-$35.7K	0.02%	122
2014 Q4	$471K	Sell	8,700 -697,154	-99%	-$38.8M	0.02%	122
2014 Q3	$39.9M	Sell	705,854 -124,840	-15%	-$7.01M	1.47%	40
2014 Q2	$45.9M	Sell	830,694 -2,866	-0.3%	-$156K	1.63%	37
2014 Q1	$45.2M	Sell	833,560 -261,623	-24%	-$13.5M	1.71%	34
2013 Q4	$52.3M	Sell	1,095,183 -3,762	-0.3%	-$172K	2.01%	12
2013 Q3	$49.9M	Sell	1,098,945 -130,074	-11%	-$5.94M	2.07%	10
2013 Q2	$54.5M	Buy	+1,229,019	New	+$54.9M	2.15%	9

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudson Edge Investment Partners's MRK Position: Q1 2025 in Review

Hudson Edge Investment Partners sold out of Merck (MRK) in Q1 2025, closing a stake of 4,849 shares — an estimated $482K sold.

Hudson Edge Investment Partners first reported a position in MRK in Q2 2013 and held it in 46 quarters. The position peaked at $54.5M in Q2 2013. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Hudson Edge Investment Partners reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Hudson Edge Investment Partners sold 4,849 Merck shares in Q1 2025, an estimated $482K.
Hudson Edge Investment Partners first reported a position in Merck in Q2 2013 and held it in 46 quarters.
Hudson Edge Investment Partners's Merck position peaked at $54.5M in Q2 2013.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Hudson Edge Investment Partners's 13F filing for Q1 2025, filed 28 Apr 2025.